The FDA today issued a public health advisory about reports of a rare brain infection in people using the psoriasis drug Raptiva.
According to the FDA, there have been three confirmed and one possible case of progressive multifocal leukoencephalopathy (PML) in people taking Raptiva; three of those people died.
Psoriasis Drug Raptiva Tied to Brain Infection
A 31-year-old Georgia woman has been charged with murder by police who say she took pills...
New guidelines for managing cholesterol call for more aggressive prevention and earlier treatment, including a recommendation...
